Graham Capital Management, L.P. Karyopharm Therapeutics Inc. Transaction History

Graham Capital Management, L.P.

  • $4.42 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 22, 2023
BUY
$1.14 - $1.81 $22,680 - $36,009
19,895 Added 31.88%
82,309 $110,000
Q2 2023

Aug 14, 2023
BUY
$1.79 - $4.59 $111,721 - $286,480
62,414 New
62,414 $111,000
Q1 2022

May 16, 2022
SELL
$5.91 - $14.38 $74,572 - $181,446
-12,618 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$5.21 - $8.61 $65,739 - $108,640
12,618 New
12,618 $81,000

Others Institutions Holding KPTI

# of Institutions
97
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $54.3M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email